MICHAEL J. DEPPE - 26 Oct 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
VP, Corp. Controller & CAO
Signature
William J. O'Shaughnessy, Jr. Attorney in Fact for Michael J. Deppe
Issuer symbol
DGX
Transactions as of
26 Oct 2022
Transactions value $
-$2,247,065
Form type
4
Filing time
27 Oct 2022, 17:35:21 UTC
Previous filing
20 May 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $476K +9.13K +28.51% $52.17 41.1K 26 Oct 2022 Direct F1
transaction DGX Common Stock Options Exercise $358K +6.37K +15.49% $56.12 47.5K 26 Oct 2022 Direct F1
transaction DGX Common Stock Sale -$2.25M -15.5K -32.62% $145.00 32K 26 Oct 2022 Direct F1, F2
holding DGX 401(k) 662 26 Oct 2022 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$476K -9.13K -100% $52.17 0 26 Oct 2022 Common Stock 9.13K $52.17 Direct F1, F4
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$358K -6.37K -100% $56.12 0 26 Oct 2022 Common Stock 6.37K $56.12 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.
F2 The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
F3 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F4 The options vested in three annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.
F5 The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016.